Literature DB >> 33457359

Portal Vein Thrombosis Secondary to Occult Polycythemia Vera.

Antón Fr Gameiro1, António Robalo Nunes1, Paula Guerra1, Estela Mateus1, Fátima Fernandes1.   

Abstract

Portal vein thrombosis (PVT) is an uncommon finding in patients without cirrhosis. The underlying x\aetiology is challenging and the condition has a wide differential diagnosis. We present a case of PVT in an anaemic patient with chronic iron and folic acid deficiency masking underlying polycythemia vera (PV). Only a careful review of the patient's clinical history allowed the identification of a short period of laboratory erythrocytosis, 6 months before the clinical onset of PVT, while the patient was on iron and folic acid supplementation. The finding raised clinical suspicion of PV previously masked by iron deficiency anaemia. Subsequent investigation confirmed the presence of the JAK2 V617F mutation and, ultimately, showed that the patient met all diagnostic criteria for PV. Myeloproliferative disorders (MPD) are associated with systemic prothrombotic states. PV is distinguished clinically from other MPD by the presence of increased red blood cell mass. Moreover, patients with abnormal haematocrit values in the pre-JAK2 V617F era may have had occult or latent PV. Diagnosis confirmation requires a combination of major and minor criteria to capture occasional cases of occult PV. This case emphasizes the importance of always considering MPD in the aetiological investigation of PVT, even in patients who apparently do not fulfil the diagnostic criteria. LEARNING POINTS: We describe a rare gastroenterological presentation of a haematological condition, which provided an unexpected diagnosis.Myeloproliferative disorders should always be considered in the investigation of portal vein thrombosis. © EFIM 2020.

Entities:  

Keywords:  Ascites; anaemia; iron deficiency; polycythemia vera; portal vein thrombosis

Year:  2020        PMID: 33457359      PMCID: PMC7806286          DOI: 10.12890/2020_002003

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  6 in total

Review 1.  Erythromelalgia and vascular complications in polycythemia vera.

Authors:  J J Michiels
Journal:  Semin Thromb Hemost       Date:  1997       Impact factor: 4.180

2.  Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.

Authors:  Ayalew Tefferi; Tiziano Barbui
Journal:  Am J Hematol       Date:  2018-11-09       Impact factor: 10.047

3.  JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.

Authors:  Francesco Dentali; Alessandro Squizzato; Lorenza Brivio; Lorena Appio; Leonardo Campiotti; Mark Crowther; Anna Maria Grandi; Walter Ageno
Journal:  Blood       Date:  2009-03-09       Impact factor: 22.113

4.  Polycythemia vera masked due to severe iron deficiency anemia.

Authors:  Shweta Kambali; Asma Taj
Journal:  Hematol Oncol Stem Cell Ther       Date:  2016-09-02

Review 5.  Dysregulated iron metabolism in polycythemia vera: etiology and consequences.

Authors:  Yelena Z Ginzburg; Maria Feola; Eran Zimran; Judit Varkonyi; Tomas Ganz; Ronald Hoffman
Journal:  Leukemia       Date:  2018-07-24       Impact factor: 11.528

Review 6.  Etiology and Complications of Portal Vein Thrombosis.

Authors:  Jonel Trebicka; Christian P Strassburg
Journal:  Viszeralmedizin       Date:  2014-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.